|
Volumn 21, Issue 6, 2006, Pages 475-484
|
In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
7-HYDROXYCOUMARIN;
ANTICOAGULANT AGENT;
COTININE;
COUMARIN;
COUMARIN 7 HYDROXYLASE;
COUMARIN 7-HYDROXYLASE;
COUMARIN DERIVATIVE;
DRUG DERIVATIVE;
MELILOTUS EXTRACT;
MIXED FUNCTION OXIDASE;
MONOXERUTIN;
NICOTINE;
NICOTINE GUM;
NICOTINIC AGENT;
POLYMETHACRYLIC ACID DERIVATIVE;
POLYVINYL DERIVATIVE;
UMBELLIFERONE;
UMBELLIFERONE DERIVATIVE;
UNCLASSIFIED DRUG;
UNSPECIFIC MONOOXYGENASE;
ADOLESCENT;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG COMBINATION;
FEMALE;
GENE FREQUENCY;
GENETIC POLYMORPHISM;
GENETICS;
GENOTYPE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PHENOTYPE;
THAILAND;
URINE;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTICOAGULANTS;
AREA UNDER CURVE;
ARYL HYDROCARBON HYDROXYLASES;
COTININE;
COUMARINS;
DRUG COMBINATIONS;
FEMALE;
GENE FREQUENCY;
GENOTYPE;
HUMANS;
HYDROXYETHYLRUTOSIDE;
MALE;
MIDDLE AGED;
MIXED FUNCTION OXYGENASES;
NICOTINE;
NICOTINIC AGONISTS;
PHENOTYPE;
POLYMETHACRYLIC ACIDS;
POLYMORPHISM, GENETIC;
POLYVINYLS;
THAILAND;
UMBELLIFERONES;
|
EID: 33847726245
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.21.475 Document Type: Article |
Times cited : (39)
|
References (0)
|